When Suddenly Everything Is About the Transition

Your arm is broke, 'cause you're trans

“Trans Broken Arm Syndrome” and Why Good Medicine Has to Be More Than Assumptions

A trans person walks into an emergency room with a broken arm. Within a few minutes, the conversation is no longer about the fracture but about hormones, surgeries, or the transition.

Hardly anyone would seriously claim that hormone therapy caused a broken bone. And yet this exaggerated example describes a pattern that many trans people know from personal experience. Within the community, it has been known for years as “Trans Broken Arm Syndrome” [12].

The term is deliberately humorous. Behind it, however, lies a serious healthcare problem that has now also been described scientifically.

When Identity Becomes the Default Explanation

Doctors work with probabilities. Symptoms are assessed, possible causes are weighed against one another, and then investigated in a targeted way. That is not a flaw. It is the core of clinical work.

It becomes problematic when one single piece of information determines the entire diagnostic perspective.

With trans people, this happens again and again. As soon as it becomes known that someone is trans or is receiving gender-affirming hormone therapy, symptoms are prematurely linked to the transition. Not because that is medically the most plausible explanation, but because this one piece of information unconsciously structures the rest of the thought process.

Headaches become “maybe it’s the hormones.” A depressive episode becomes “maybe you regret the transition.” Stomach problems become “that could be related to your hormone therapy.” Meanwhile, more obvious causes initially remain unconsidered.

That is exactly the pattern meant by “Trans Broken Arm Syndrome.”

From a Community Term to a Subject of Research

For a long time, the expression was used exclusively within the trans community. In 2023, Catherine S. J. Wall, Alison J. Patev, and Eric G. Benotsch published a study in Social Science & Medicine that systematically examined these experiences for the first time [1].

For the scientific description, they introduced the term Gender-related Medical Misattribution and Invasive Questioning (GRMMIQ).

They distinguish between two forms.

The first is causal misattribution: an acute complaint is attributed to gender identity or medical transition without sufficient basis.

The second is invasive questioning: healthcare professionals ask highly personal questions about gender identity or transition status that are irrelevant to the current diagnosis.

Someone who comes to a doctor with tonsillitis, a sports injury, or a cold normally does not have to answer questions about their genitals, surgeries, or hormone status. And yet trans people regularly report exactly that.

What the Study Shows

The study surveyed 147 trans and nonbinary people in the United States who had been recruited through an online platform. Those who reported having experienced GRMMIQ were then able to describe such a situation in a free-text field [1].

Nearly one third of respondents reported having experienced at least one form of GRMMIQ. More than one quarter described invasive questions about gender identity or transition that had no relevance to their treatment. Around thirteen percent reported that an acute complaint had been attributed to their gender identity or transition [1].

From the free-text responses, the authors identified four recurring themes. First, the assumption of disturbed thinking or perception. Second, an excessive focus on individual aspects of medical transition. Third, cultural ignorance and a lack of competence on the part of healthcare professionals. Fourth, a dismissive or demeaning response to the symptoms described [1].

These experiences were statistically associated with whether respondents were out to healthcare professionals in acute care and with other forms of gender-related discrimination in healthcare [1].

An important point for context: this was a convenience sample from the US healthcare system, not a representative survey. The percentages therefore cannot be treated as prevalence estimates for Germany. What the study does accomplish is something different and still highly significant: it turns an experience that had previously been shared mainly through anecdotes into a definable and researchable category. That is the prerequisite for a phenomenon to be measured and addressed at all.

Why Does This Happen?

Trans health is still firmly integrated into only a small number of medical degree programs. Many doctors therefore encounter trans patients only rarely and have little practical experience. This uncertainty can lead the one piece of information they believe they understand to receive disproportionate weight.

In decision-making research, this pattern is known as the anchoring effect (anchoring bias), described as early as 1974 by Amos Tversky and Daniel Kahneman [2]. Information that becomes available early influences later judgment more strongly than is objectively justified.

The information “This person is trans” can therefore become a mental anchor. Everything that follows is viewed through that lens, even though completely different causes may objectively be far more likely.

In clinical literature, there is a separate term for the diagnostic version of this error: diagnostic overshadowing. This means attributing new or unrelated symptoms to an already known diagnosis or characteristic without seriously investigating other possible causes. The term originally came from the care of people with intellectual disabilities and is now used much more broadly. Delayed diagnoses, inadequate treatment, and an increased risk of adverse events are among the documented consequences [3].

The phenomenon is therefore not a special problem unique to trans people but a well-known cognitive error with a new point of anchoring.

A Longstanding Problem in Medicine

Comparable patterns can be found in other patient groups.

An analysis of nearly 3,000 young heart attack patients in the VIRGO study showed that women were more likely to interpret their symptoms as stress or anxiety and more likely than men to report that their healthcare providers did not believe the symptoms were heart-related. The majority of both groups had reported chest pain as their primary symptom [8].

People with obesity regularly report that pain or other symptoms are broadly attributed to their weight before any proper diagnostic evaluation takes place.

People with disabilities experience new symptoms being automatically interpreted as manifestations of their existing disability.

So the actual problem is not the transition. It is that one known characteristic of a person dominates the entire diagnostic perspective.

What Is the Situation in Germany?

There are currently no robust German figures specifically on GRMMIQ. However, the third major LGBTI survey by the EU Agency for Fundamental Rights from 2024 provides clear indications regarding experiences of discrimination in healthcare more generally.

Across the EU, fourteen percent of all respondents said they had felt discriminated against in healthcare during the year before the survey. In Germany, the figure was fifteen percent. Among trans men, it was forty percent; among trans women thirty-nine percent, and among intersex respondents thirty-one percent. Germany represented the largest national subsample at seventeen percent [4].

Another finding from the German analysis is notable. As a reason for not accessing desired gender-affirming treatment, eighteen percent of trans women and fourteen percent of trans men explicitly cited negative reactions from doctors or medical staff [5].

There is also a structural gap. The relevant S3 guideline, Gender Incongruence, Gender Dysphoria and Trans Health, was published in the AWMF register in October 2018. Its validity has expired, and it has been under revision for some time [10, 11]. Healthcare professionals who want to rely on a current, consensus-based German recommendation therefore currently have none available.

Does That Mean Hormones Never Play a Role?

Of course not.

Gender-affirming hormone therapies have medically relevant effects. Depending on the medication, method of administration, and individual circumstances, they can influence blood pressure, coagulation, lipid profiles, bone metabolism, or liver values, among other things [9]. If the symptoms described are consistent with such effects, hormone therapy absolutely belongs in the differential diagnosis.

Good medicine means establishing such connections through symptom patterns and evidence, not through the mere fact that someone is trans. Transition should neither reflexively become the explanation for every complaint nor be ignored entirely. Both are mistakes, and the second is often overlooked in this debate.

In practice, this means two things above all. First, reference ranges for many laboratory parameters are hormone-dependent, and the sex marker stored in the system is not always the appropriate reference point. Second, preventive care should be based on the organs a person has, not on their legal sex. A trans woman who has not had a prostatectomy still has a prostate. A trans man who still has a cervix still needs the relevant screening [9].

At this point, the issue also becomes one of documentation. If an information system contains only one binary sex field but no structured organ inventory, then incorrect classification may already be built into the dataset and reproduced during every subsequent treatment. The anchor then exists not only in the clinician’s mind, but in the form itself.

The Consequences Go Far Beyond an Unpleasant Doctor’s Visit

Anyone who repeatedly experiences their symptoms not being taken seriously loses trust. And when trust is lost, people seek care later or not at all.

The 2022 US Transgender Survey, with more than 92,000 participants, is the largest survey of its kind and demonstrates this clearly. Almost half of respondents who had sought medical care in the year before the survey reported at least one negative experience related to being trans. Around one quarter avoided a necessary doctor’s visit out of fear of mistreatment. That figure was at roughly the same level as in the previous survey from 2015 [6, 7].

A single frustrating appointment can therefore develop into a long-term health risk. Preventive screenings are used less often, illnesses are detected later, and treatment begins with delays. This is not a matter of hurt feelings. It is a healthcare problem with measurable consequences.

What Actually Helps

For healthcare professionals, the most effective step may lie less in specialist knowledge than in one routine question to themselves: Would I ask a cis person with the same symptoms this question too? If the answer is no, the question is probably serving personal curiosity rather than diagnosis.

It can also help to explicitly identify the anchor. Anyone who consciously notices that information about a transition is currently structuring the thought process can deliberately set it aside and run through the differential diagnosis once again without it. That takes seconds.

For trans people themselves, the burden is unfairly distributed, but it can help to frame the reason for the visit narrowly at the beginning, for example by stating that today’s appointment is only about one specific symptom, and to bring information about hormone medications, including dosage and method of administration. That removes some of the uncertainty on the other side.

Structurally, both are needed: trans health as a permanent component of medical education and continuing training, and documentation systems that can record gender identity, administrative sex, and medically relevant physical characteristics separately.

Good Medicine Treats People, Not Assumptions

Most doctors want to help their patients and do excellent work. “Trans Broken Arm Syndrome” is not an accusation against an entire profession. It is a reminder of how easily habits of thought can quietly get in the way of evidence.

A trans person can develop the same illnesses as anyone else. They can break an arm, develop pneumonia, or suffer from migraines.

The first diagnostic question should therefore always be:

“Which causes are most likely based on the symptoms?”

And not:

“Which explanation fits the fact that this person is trans?”

That is exactly where the difference lies between assumption and evidence-based medicine.

Yours, Lizbeth

Sources

1. Wall, C. S. J., Patev, A. J., & Benotsch, E. G. (2023). Trans broken arm syndrome: A mixed-methods exploration of gender-related medical misattribution and invasive questioning. Social Science & Medicine, 320, 115748. https://doi.org/10.1016/j.socscimed.2023.115748

2. Tversky, A., & Kahneman, D. (1974). Judgment under Uncertainty: Heuristics and Biases. Science, 185(4157), 1124–1131. https://doi.org/10.1126/science.185.4157.1124

3. Hallyburton, A. (2022). Diagnostic overshadowing: An evolutionary concept analysis on the misattribution of physical symptoms to pre-existing psychological illnesses. International Journal of Mental Health Nursing, 31(6), 1360–1372. https://doi.org/10.1111/inm.13034

4. European Union Agency for Fundamental Rights (2024). LGBTIQ equality at a crossroads: progress and challenges. https://fra.europa.eu/en/publication/2024/lgbtiq-equality-crossroads-progress-and-challenges

5. Lesben- und Schwulenverband in Deutschland (2024). Diskriminierung und Gewalterfahrungen von LSBTIQ in Deutschland: Ergebnisse des dritten großen LGBTI-Survey.* https://www.lsvd.de/de/ct/3111-Diskriminierung-und-Gewalterfahrungen-von-LSBTIQ-in-Deutschland-Ergebnisse-des-dritten-grossen-LGBTI-Survey

6. James, S. E., Herman, J. L., Durso, L. E., & Heng-Lehtinen, R. (2024). Early Insights: A Report of the 2022 U.S. Transgender Survey. National Center for Transgender Equality. https://ustranssurvey.org/report/health/

7. National Center for Transgender Equality (2025). Health & Wellbeing: Findings from the 2022 U.S. Trans Survey. https://transequality.org/sites/default/files/2025-06/USTS_2022Health&WellbeingReport_WEB.pdf

8. Lichtman, J. H., et al. (2018). Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study. Circulation, 137(8), 781–790. https://doi.org/10.1161/CIRCULATIONAHA.117.031650

9. Coleman, E., et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(S1), S1–S259. https://doi.org/10.1080/26895269.2022.2100644

10. Deutsche Gesellschaft für Sexualforschung (2018). Geschlechtsinkongruenz, Geschlechtsdysphorie und Trans-Gesundheit: S3-Leitlinie zur Diagnostik, Beratung und Behandlung. AWMF-Registernr. 138/001. https://register.awmf.org/de/leitlinien/detail/138-001

11. Nieder, T. O., & Strauß, B. (2019). S3-Leitlinie zur Diagnostik, Beratung und Behandlung im Kontext von Geschlechtsinkongruenz, Geschlechtsdysphorie und Trans-Gesundheit: Hintergrund, Methode und zentrale Empfehlungen. Zeitschrift für Sexualforschung, 32(2), 70–79.

12. PinkNews (2025). What is "trans broken arm syndrome" and how can we help stop it? https://www.thepinknews.com/2025/05/21/trans-broken-arm-syndrome-explainer/